CClinicalTrials.gg
Not yet recruitingNCT07627243IPT-A-SCIUpdated Jun 11, 2026

Brief Crisis Therapy for Suicidal Children and Adolescents

An interventional study of IPT-A-SCI in Suicidal Ideation and Suicidal Behavior, sponsored by Tel Aviv University. Not yet recruiting at 1 site in Israel. Open to participants aged 8 Years to 18 Years. Per ClinicalTrials.gov, last updated 2026-06-11.

Sponsored by Tel Aviv University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Not applicable
Ages
8 Years to 18 Years
Sex
All
01

Study summary

The goal of this clinical trial is to learn if the Ultra-Brief Interpersonal Psychotherapy for Adolescents with Suicidal Ideation (IPT-A-SCI) works to reduce suicidal thoughts and behaviors in children and adolescents. The study will also examine whether treatment effects continue after treatment ends and whether some participants benefit more from the intervention than others. The main questions it aims to answer are:

Does IPT-A-SCI reduce suicidal thoughts and behaviors in children and adolescents? Do the effects of IPT-A-SCI continue three months after treatment ends? Do some children and adolescents benefit more from IPT-A-SCI than others?

Participants will:

Receive IPT-A-SCI treatment consisting of five weekly sessions Complete questionnaires before treatment, during treatment, at the end of treatment, and three months after treatment ends Have their parents complete questionnaires at the same time points

Read the detailed description

IPT-A-SCI (Ultra-Brief Crisis Interpersonal Psychotherapy for Adolescents with Suicidal Ideation) is a manualized five-session crisis intervention based on Interpersonal Psychotherapy (IPT) principles.

IPT-A-SCI is designed for children and adolescents aged 8-18 presenting with suicidal ideation or behavior. The intervention combines IPT principles with the Safety Planning Intervention and includes a three-month post-intervention contact protocol.

This is a single-group, pre-post interventional study with repeated measures collected at four time points. All participants will receive the IPT-A-SCI intervention. There is no control or comparison group in this study, as the research focuses on within-person mechanisms of change and moderators of treatment response rather than between-group comparisons.

Participants will be recruited from the Child and Adolescent Clinic at Geha Mental Health Center through emergency room referrals, outpatient providers, and treating therapists at the clinic. Initial evaluation and suicide risk assessment will be conducted by experienced clinical staff according to established clinical guidelines for suicide risk assessment in adolescents.

Up to 120 participants will be enrolled over an estimated two-year recruitment period.

During the three months following treatment, participants will receive three personalized emails at 2 weeks, 1 month, and 2 months post-treatment. A follow-up session will take place three months after treatment completion. Psychiatric or psychosocial treatment may continue as usual during IPT-A-SCI.

Statistical Analysis Plan:

Three complementary analytic frameworks will be used:

  1. Modeling within-person change across therapy
  2. Examining associations between changes in proposed mechanisms of change and changes in suicidality
  3. Identifying participant characteristics associated with differential treatment response Individual Growth Curve Modeling (IGCM) will be used to examine trajectories of change across the four assessment time points for proposed mechanisms of change, including hope, perceived social support, emotional processing, family conflict, and interpersonal functioning.

Latent Change Score (LCS) modeling will be used to assess changes in suicidal ideation and related clinical outcomes from baseline to post-treatment and follow-up. Associations between changes in proposed mechanisms and changes in suicidality will be examined to identify factors that may contribute to treatment effectiveness.

Linear Mixed-Effects Models (LMMs) will be used to examine whether treatment effectiveness varies according to baseline participant characteristics, including initial suicide risk severity and other demographic and clinical variables. These analyses will identify moderators of treatment response and determine which participants derive the greatest benefit from the intervention.

Missing data will be handled in accordance with established best practices for longitudinal clinical research. The analytic approaches described above accommodate missing data under missing-at-random assumptions.

Data Collection and Management:

  • Questionnaires will be completed by participants and parents at all assessment time points.
  • The Columbia-Suicide Severity Rating Scale (C-SSRS) will be administered by clinicians during treatment sessions.
  • A unique trial identification number will be assigned at recruitment and used across all study materials.
  • All study data will be retained in accordance with Good Clinical Practice (GCP) guidelines.

Safety Monitoring and Ethical Considerations:

This study focuses on children and adolescents at risk for suicide. The Child and Adolescent Clinic at Geha Mental Health Center is located on the grounds of a psychiatric hospital with a 24/7 emergency room. Participants presenting with acute suicidal crisis during the study may be referred immediately for emergency psychiatric evaluation.

All treating clinicians are trained in suicide risk assessment and management. Adverse events, including worsening suicidal ideation or behavior, will be documented and reported in accordance with Helsinki Committee requirements and Good Clinical Practice guidelines.

No formal Data Safety Monitoring Board (DSMB) is in place for this study given its single-site naturalistic design. Clinical oversight will be provided through routine supervision and case conferencing.

02

Conditions studied

  • Suicidal Ideation
  • Suicidal Behavior

Keywords

  • suicidal ideation
  • suicidal behavior
  • Interpersonal psychotherapy
  • children
  • adolescents
  • Suicide prevention
  • Safety planning
  • Brief intervention
03

Who can participate

Ages eligible
8 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Children and adolescents aged 8-18 years presenting with suicidal ideation or behavior
  • Suicide risk assessment indicating suitability for outpatient treatment,
  • Fluency in Hebrew
  • Ability to attend five weekly treatment sessions
  • Written informed consent provided by parents or legal guardians
  • Written informed assent/consent provided by participants in accordance with age and local ethical regulations

Exclusion criteria

Exclusion Criteria:

  • Acute medical or psychiatric condition requiring immediate inpatient treatment
  • Linguistic, developmental, neurological, or intellectual limitations that prevent understanding of the treatment protocol or study procedures
  • Inability to participate in outpatient psychotherapy
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
120 participants (estimated)

Study arms

  • Experimental
    IPT-A-SCI

    Participants will receive the IPT-A-SCI intervention consisting of five weekly sessions of ultra-brief interpersonal psychotherapy combined with safety planning for suicidal ideation and behavior.

    Behavioral: IPT-A-SCI

Interventions

  • BehavioralIPT-A-SCI

    Manualized ultra-brief interpersonal psychotherapy intervention combined with safety planning for children and adolescents with suicidal ideation or behavior.

05

What researchers measure

Primary outcomes

  1. Change in Severity of Suicidal Ideation

    Change in severity of suicidal ideation and behavior assessed using the Columbia-Suicide Severity Rating Scale (C-SSRS). The C-SSRS assesses the severity of suicidal ideation and the occurrence of suicidal behaviors. The suicidal ideation severity score ranges from 1 to 5, with higher scores indicating greater severity of suicidal ideation.

    Time frame: Baseline to 3-month follow-up

Secondary outcomes

  1. Change in Intensity of Suicidal Ideation

    Change in intensity of suicidal ideation assessed using the Columbia-Suicide Severity Rating Scale (C-SSRS) ideation intensity scale. The C-SSRS assesses the intensity of the most severe suicidal ideation endorsed by evaluating five dimensions: frequency, duration, controllability, deterrents, and reasons for ideation. Total scores range from 0 to 25, with a score of 0 assigned when no suicidal ideation is endorsed and scores from 2 to 25 indicating increasing intensity of suicidal ideation. Higher scores indicate more intense suicidal ideation and a worse outcome.

    Time frame: Baseline to 3-month follow-up

  2. Change in Depressive Symptoms

    Change in depressive symptoms assessed using the Short Mood and Feelings Questionnaire (SMFQ). Scores range from 0 to 26, with higher scores indicating greater depressive symptom severity and a worse outcome.

    Time frame: Baseline to 3-month follow-up

  3. Change in Perceived Social Support

    Change in perceived social support assessed using the Multidimensional Scale of Perceived Social Support (MSPSS). Scores range from 12 to 84, with higher scores indicating greater perceived social support and a better outcome.

    Time frame: Baseline to 3-month follow-up

  4. Change in Emotional Processing (Alexithymia)

    Change in emotional processing and alexithymia assessed using the Toronto Alexithymia Scale (TAS-20). Scores range from 20 to 100, with higher scores indicating greater difficulty identifying and describing emotions (greater alexithymia) and a worse outcome.

    Time frame: Baseline to 3-month follow-up

  5. Change in Hope

    Change in hope assessed using the Children's Hope Scale (CHS). Scores range from 6 to 36, with higher scores indicating greater hopefulness and a better outcome.

    Time frame: Baseline to 3-month follow-up

  6. Change in Family Conflict and Interpersonal Stress

    Change in family conflict and interpersonal stress assessed using the Family Environment Scale (FES) conflict subscale. Scores range from 0 to 9, with higher scores indicating greater family conflict and a worse outcome.

    Time frame: Baseline to 3-month follow-up

  7. Change in Irritability and Emotional Dysregulation

    Change in irritability and emotional dysregulation assessed using the parent-report TIDES-13 questionnaire. Total scores range from 13 to 91, with higher scores indicating greater irritability and emotional dysregulation and a worse outcome.

    Time frame: Baseline to 3-month follow-up

  8. Change in Interpersonal and Social Functioning

    Change in interpersonal and social functioning assessed using EFORTS social routine measures. Scores range from 0 to 5. with higher scores indicating better social routine functioning and executive functioning in daily activities and therefore a better outcome.

    Time frame: Baseline to 3-month follow-up

  9. Behavioral and Emotional Problems at Baseline

    Behavioral and emotional problems assessed using the parent-report Child Behavior Checklist (CBCL). This measure will be used for descriptive and covariate analyses. Raw scores vary according to age and sex and are converted to standardized T-scores. Higher T-scores indicate greater emotional and behavioral problems and a worse outcome.

    Time frame: Baseline only

06

Study locations

1 site
  • Geha Mental Health Center
    Petah Tikva, Israel
    • Chamutal Saragusty, MA · Contact · yanivchamutal@gmail.com · 972-52-3400936
    • Chamutal Saragusty, MA · Principal investigator
07

References and documents

Publications

  • Stanley B, Brown GK. Safety Planning Intervention: A Brief Intervention to Mitigate Suicide Risk. Cogn Behav Pract. 2012;19(2):256-264. doi:10.1016/j.cbpra.2011.01.001.
  • Itzhaky L, Davaasambuu S, Ellis SP, Cisneros-Trujillo S, Hannett K, Scolaro K, Stanley BH, Mann JJ, Wainberg ML, Oquendo MA, Sublette ME. Twenty-six years of psychosocial interventions to reduce suicide risk in adolescents: Systematic review and meta-analysis. J Affect Disord. 2022 Mar 1;300:511-531. doi: 10.1016/j.jad.2021.12.094. Epub 2021 Dec 31. PubMed 34974074 ↗
  • Lipsitz JD, Markowitz JC. Mechanisms of change in interpersonal therapy (IPT). Clin Psychol Rev. 2013 Dec;33(8):1134-47. doi: 10.1016/j.cpr.2013.09.002. Epub 2013 Sep 25. PubMed 24100081 ↗
  • Adini-Spigelman E, Gvion Y, Haruvi Catalan L, Barzilay S, Apter A, Brunstein Klomek A. Comparative Effectiveness of Ultra-Brief, IPT-A Based Crisis Intervention for Suicidal Children and Adolescents. Arch Suicide Res. 2024 Oct-Dec;28(4):1249-1262. doi: 10.1080/13811118.2023.2298499. Epub 2024 Jan 3. PubMed 38169321 ↗
  • Haruvi Catalan L, Levis Frenk M, Adini Spigelman E, Engelberg Y, Barzilay S, Mufson L, Apter A, Benaroya Milshtein N, Fennig S, Klomek AB. Ultra-Brief Crisis IPT-A Based Intervention for Suicidal Children and Adolescents (IPT-A-SCI) Pilot Study Results. Front Psychiatry. 2020 Dec 9;11:553422. doi: 10.3389/fpsyt.2020.553422. eCollection 2020. PubMed 33362595 ↗

Individual participant data

Plan to share: Undecided

08

Registry details

Key details

Study ID
NCT07627243
Lead sponsor
Tel Aviv University
Collaborators
Geha Mental Health Center
Responsible party
Chamutal Saragusty (Clinical Psychologist, M.A., Ph.D. Student, Tel Aviv University, Tel Aviv University) — Principal investigator
First posted
Jun 4, 2026
Start date
Jun 2026 (estimated)
Primary completion
Jun 2028 (estimated)
Completion
Jun 2028 (estimated)
Last update
Jun 11, 2026

Study contacts

Chamutal Saragusty, MA
Contact
yanivchamutal@gmail.com
972-52-3400936
Chamutal Saragusty, MA
principal investigator · Geha Mental Health Center and Tel Aviv University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion